Veracyte, Inc. (VCYT)
NASDAQ: VCYT · IEX Real-Time Price · USD
23.18
-0.75 (-3.13%)
At close: Jul 19, 2024, 4:00 PM
23.58
+0.40 (1.73%)
Pre-market: Jul 22, 2024, 6:00 AM EDT

Veracyte Revenue

Veracyte had revenue of $375.47M in the twelve months ending March 31, 2024, with 20.66% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $96.84M with 17.50% year-over-year growth. In the year 2023, Veracyte had annual revenue of $361.05M with 21.76% growth.

Revenue (ttm)
$375.47M
Revenue Growth
+20.66%
P/S Ratio
4.72
Revenue / Employee
$460,703
Employees
815
Market Cap
1.77B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023361.05M64.52M21.76%
Dec 31, 2022296.54M77.02M35.09%
Dec 31, 2021219.51M102.03M86.85%
Dec 31, 2020117.48M-2.89M-2.40%
Dec 31, 2019120.37M28.36M30.82%
Dec 31, 201892.01M20.06M27.87%
Dec 31, 201771.95M6.87M10.55%
Dec 31, 201665.09M15.58M31.48%
Dec 31, 201549.50M11.31M29.62%
Dec 31, 201438.19M16.31M74.51%
Dec 31, 201321.88M10.26M88.20%
Dec 31, 201211.63M8.98M339.62%
Dec 31, 20112.65M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harmony Biosciences Holdings 617.51M
Zai Lab 291.07M
Ligand Pharmaceuticals 118.31M
RxSight 101.10M
Keros Therapeutics 234.00K
Revenue Rankings